BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Chuan Xie, Nong-Hua Lu. Review: Clinical Management ofHelicobacter pyloriInfection in ChinaHelicobacter 2015; 20(1): 1 doi: 10.1111/hel.12178
2
Antonio Francesco Ciccaglione, Luigina Cellini, Leonardo Marzio. Pylera® plus ranitidine vs Pylera® plus esomeprazole in first‐line treatment of Helicobacter pylori infection: Two pilot studies Helicobacter 2019; 24(5) doi: 10.1111/hel.12606
3
Gijsbert B. van der Voet. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactionsSide Effects of Drugs Annual 2010; 32: 413 doi: 10.1016/S0378-6080(10)32022-8
4
Xiao-Min Liao, Gao-Hui Nong, Mei-Zu Chen, Xue-Ping Huang, Yun-Yan Cong, Yi-Ying Huang, Bai-He Wu, Jin-Qi Wei. Modified sequential therapy <italic>vs</italic> quadruple therapy as initial therapy in patients with <italic>Helicobacter</italic> infectionWorld Journal of Gastroenterology 2015; 21(20): 6310-6316 doi: 10.3748/wjg.v21.i20.6310
5
Bruce A. Fowler, Dexter W. Sullivan, Mary J. Sexton. Handbook on the Toxicology of Metals2015; : 655 doi: 10.1016/B978-0-444-59453-2.00031-7
6
Yiqiao Xin, Jan Manson, Lindsay Govan, Robin Harbour, Jenny Bennison, Eleanor Watson, Olivia Wu. Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysisBMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0491-7
7
Peter Malfertheiner. Helicobacter pylori eradication – Author's replyThe Lancet 2011; 378(9788): 314 doi: 10.1016/S0140-6736(11)61161-6
8
Wen Zhong Liu, Yong Xie, Hong Cheng, Nong Hua Lu, Fu Lian Hu, Wan Dai Zhang, Li Ya Zhou, Ye Chen, Zhi Rong Zeng, Chong Wen Wang, Shu Dong Xiao, Guo Zong Pan, Pin Jin Hu. Fourth Chinese National Consensus Report on the management ofHelicobacter pyloriinfectionJournal of Digestive Diseases 2013; 14(5): 211 doi: 10.1111/1751-2980.12034
9
J. C. Delchier, P. Malfertheiner, R. Thieroff-Ekerdt. Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication ofHelicobacter pyloriAlimentary Pharmacology & Therapeutics 2014; 40(2): 171 doi: 10.1111/apt.12808
10
Anthony O'Connor, Javier Gisbert, Colm O’Morain. Treatment ofHelicobacter pyloriInfectionHelicobacter 2009; 14: 46 doi: 10.1111/j.1523-5378.2009.00704.x
11
Anthony O’Connor, Javier P. Gisbert, Deirdre McNamara, Colm O’Morain. Treatment of Helicobacter pylori Infection 2010Helicobacter 2010; 15: 46 doi: 10.1111/j.1523-5378.2010.00774.x
12
Annu Aggarwal, Mohit Bhatt. Neurologic Aspects of Systemic Disease Part IIHandbook of Clinical Neurology 2014; 120: 633 doi: 10.1016/B978-0-7020-4087-0.00043-7
13
Vincenzo De Francesco, Enzo Ierardi, Cesare Hassan, Angelo Zullo. Is Furazolidone Therapy for Helicobacter pylori Effective and Safe?Digestive Diseases and Sciences 2009; 54(10): 2298 doi: 10.1007/s10620-009-0748-x
14
P Malfertheiner, F Megraud, C A O'Morain, J P Gisbert, E J Kuipers, A T Axon, F Bazzoli, A Gasbarrini, J Atherton, D Y Graham, R Hunt, P Moayyedi, T Rokkas, M Rugge, M Selgrad, S Suerbaum, K Sugano, E M El-Omar. Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus ReportGut 2017; 66(1): 6 doi: 10.1136/gutjnl-2016-312288
15
Bilal Ergül, Zeynal Doğan, Murat Sarikaya, Levent Filik. The Efficacy of Two-Week Quadruple First-Line Therapy with Bismuth, Lansoprazole, Amoxicillin, Clarithromycin onHelicobacter pyloriEradication: A Prospective StudyHelicobacter 2013; 18(6): 454 doi: 10.1111/hel.12086
16
Peter Malfertheiner, Franco Bazzoli, Jean-Charles Delchier, Krysztof Celiñski, Monique Giguère, Marc Rivière, Francis Mégraud. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trialThe Lancet 2011; 377(9769): 905 doi: 10.1016/S0140-6736(11)60020-2
17
Youhua Wang, Ben Wang, Zhi Fa Lv, Yang Yang, Fucai Wang, Hui Wang, Shuping Chen, Yong Xie, Xiaojiang Zhou. Efficacy and Safety of Ecabet Sodium as an Adjuvant Therapy forHelicobacter pyloriEradication: A Systematic Review and Meta-AnalysisHelicobacter 2014; 19(5): 372 doi: 10.1111/hel.12136
18
Hale Gokcan, Erkin Oztas, Ibrahim Koral Onal. Different bismuth-based therapies for eradicating Helicobacter pylori: Randomized clinical trial of efficacy and safetyClinics and Research in Hepatology and Gastroenterology 2016; 40(1): 124 doi: 10.1016/j.clinre.2015.06.014
19
Chanagune Srinarong, Sith Siramolpiwat, Arti Wongcha-um, Varocha Mahachai, Ratha-Korn Vilaichone. Improved Eradication Rate of Standard Triple Therapy by Adding Bismuth and Probiotic Supplement for Helicobacter pylori Treatment in ThailandAsian Pacific Journal of Cancer Prevention 2014; 15(22): 9909 doi: 10.7314/APJCP.2014.15.22.9909
20
Jeana Hong, Hye Ran Yang. Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy forHelicobacter pyloriEradication in Korean ChildrenPediatric Gastroenterology, Hepatology & Nutrition 2012; 15(4): 237 doi: 10.5223/pghn.2012.15.4.237
21
Hatainuch Prapitpaiboon, Varocha Mahachai, Ratha-Korn Vilaichone. High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in ThailandAsian Pacific Journal of Cancer Prevention 2015; 16(10): 4353 doi: 10.7314/APJCP.2015.16.10.4353
22
Francisco Buitrago Ramírez, Eloísa Rodríguez Torres, Javier Alejandre Carmona. Criterios actuales para la erradicación de Helicobacter pyloriFMC - Formación Médica Continuada en Atención Primaria 2010; 17(3): 158 doi: 10.1016/S1134-2072(10)70063-3
23
Stephan Miehlke, Dorothea Frederking, Thomas Günther, Erik Glocker, Bianca Eisele, Viola Andresen, Sören Schröder, Andrea Morgner. Efficacy of three-in-one capsule bismuth quadruple therapy for Helicobacter pylori eradication in clinical practice in a multinational patient populationHelicobacter 2017; 22(6): e12429 doi: 10.1111/hel.12429
24
Xiao Liang, Xiaoqing Xu, Qing Zheng, Wei Zhang, Qinjuan Sun, Wenzhong Liu, Shudong Xiao, Hong Lu. Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective StudyClinical Gastroenterology and Hepatology 2013; 11(7): 802 doi: 10.1016/j.cgh.2013.01.008
25
Daniel Pohl, Peter M Keller, Valentine Bordier, Karoline Wagner. Review of current diagnostic methods and advances in <i>Helicobacter pylori</i> diagnostics in the era of next generation sequencingWorld Journal of Gastroenterology 2019; 25(32): 4629-4660 doi: 10.3748/wjg.v25.i32.4629
26
Meyler's Side Effects of Drugs2016; : 990 doi: 10.1016/B978-0-444-53717-1.00387-5
27
Mārcis Leja, Uga Dumpis. What Would the Screen-and-Treat Strategy for Helicobacter pylori Mean in Terms of Antibiotic Consumption?Digestive Diseases and Sciences 2019;  doi: 10.1007/s10620-019-05893-z
28
Yi Hu, Yin Zhu, Nong-Hua Lu. Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic ResistanceFrontiers in Cellular and Infection Microbiology 2017; 7 doi: 10.3389/fcimb.2017.00168
29
Ben Wang, You-Hua Wang, Zhi-Fa Lv, Hui-Fang Xiong, Hui Wang, Yang Yang, Yong Xie. Review: Efficacy and Safety of Hybrid Therapy forHelicobacter pyloriInfection: A Systematic Review and Meta-analysisHelicobacter 2015; 20(2): 79 doi: 10.1111/hel.12180
30
Javier P. Gisbert, Adrian G. McNicholl. Optimization strategies aimed to increase the efficacy ofH. pylorieradication therapiesHelicobacter 2017; 22(4): e12392 doi: 10.1111/hel.12392
31
J. P. Gisbert, M. Romano, A. G. Gravina, P. Solís-Muñoz, F. Bermejo, J. Molina-Infante, M. Castro-Fernández, J. Ortuño, A. J. Lucendo, M. Herranz, I. Modolell, F. del Castillo, J. Gómez, J. Barrio, B. Velayos, B. Gómez, J. L. Domínguez, A. Miranda, M. Martorano, A. Algaba, M. Pabón, T. Angueira, L. Fernández-Salazar, A. Federico, A. C. Marín, A. G. McNicholl. Helicobacter pylorisecond-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatmentsAlimentary Pharmacology & Therapeutics 2015; 41(8): 768 doi: 10.1111/apt.13128
32
Qinjuan Sun, Xiao Liang, Qing Zheng, Wenzhong Liu, Shudong Xiao, Weiqi Gu, Hong Lu. High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori EradicationHelicobacter 2010; 15(3): 233 doi: 10.1111/j.1523-5378.2010.00758.x
33
Aamir Saleem, Asghar Qasim, Humphrey J O’Connor, Colm A O’Morain. Pylera®for the eradication ofHelicobacter pyloriinfectionExpert Review of Anti-infective Therapy 2009; 7(7): 793 doi: 10.1586/eri.09.55
34
Hidekazu Suzuki, Juntaro Matsuzaki, Toshifumi Hibi. Metronidazole-based quadruple versus standard triple therapy: which is better as first-line therapy forHelicobacter pylorieradication?Expert Review of Clinical Pharmacology 2011; 4(5): 579 doi: 10.1586/ecp.11.34
35
Paul T. Reynolds, Kathleen C. Abalos, Jennifer Hopp, Mark E. Williams. Bismuth Toxicity: A Rare Cause of Neurologic DysfunctionInternational Journal of Clinical Medicine 2012; 3(01): 46 doi: 10.4236/ijcm.2012.31010
36
Vasilios Papastergiou, Sotirios D Georgopoulos, Stylianos Karatapanis. Treatment of <italic>Helicobacter pylori</italic> infection: Meeting the challenge of antimicrobial resistanceWorld Journal of Gastroenterology 2014; 20(29): 9898-9911 doi: 10.3748/wjg.v20.i29.9898
37
Emma L. Hawksworth, Philip C. Andrews, Wilford Lie, Barry Lai, Carolyn T. Dillon. Biological evaluation of bismuth non-steroidal anti-inflammatory drugs (BiNSAIDs): Stability, toxicity and uptake in HCT-8 colon cancer cellsJournal of Inorganic Biochemistry 2014; 135: 28 doi: 10.1016/j.jinorgbio.2014.02.012
38
Peter Malfertheiner, Michael Selgrad. Helicobacter pylori infection and current clinical areas of contentionCurrent Opinion in Gastroenterology 2010; 26(6): 618 doi: 10.1097/MOG.0b013e32833efede
39
Edith Lahner, Marilia Carabotti, Bruno Annibale. Treatment of <i>Helicobacter pylori</i> infection in atrophic gastritisWorld Journal of Gastroenterology 2018; 24(22): 2373-2380 doi: 10.3748/wjg.v24.i22.2373
40
Sung Woo Ko, Yeon‐Ji Kim, Woo Chul Chung, Seung Jae Lee. Bismuth supplements as the first‐line regimen for Helicobacter pylori eradication therapy: Systemic review and meta‐analysis Helicobacter 2019; 24(2): e12565 doi: 10.1111/hel.12565
41
Su Golder, Yoon K. Loke. The performance of adverse effects search filters in MEDLINE and EMBASEHealth Information & Libraries Journal 2012; 29(2): 141 doi: 10.1111/j.1471-1842.2012.00980.x
42
Michael Selgrad, Arne Kandulski, Peter Malfertheiner. Helicobacter pylori: diagnosis and treatmentCurrent Opinion in Gastroenterology 2009; 25(6): 549 doi: 10.1097/MOG.0b013e32833159f2
43
Ersin Kılınç, Sezgin Bakırdere, Fırat Aydın, O. Yavuz Ataman. Sensitive determination of bismuth by flame atomic absorption spectrometry using atom trapping in a slotted quartz tube and revolatilization with organic solvent pulseSpectrochimica Acta Part B: Atomic Spectroscopy 2012; 73: 84 doi: 10.1016/j.sab.2012.06.004
44
Jie Liang, Jun Li, Ying Han, Jielai Xia, Yunsheng Yang, Wen Li, Shutian Zhang, Yongdong Wu, Yaozong Yuan, Zhaoshen Li, Yiqi Du, Minhu Chen, Baili Chen, Bo Jiang, Yang Bai, Qinsheng Wen, Kaichun Wu, Daiming Fan. Helicobacter pyloriEradication with Ecabet Sodium, Omeprazole, Amoxicillin, and Clarithromycin Versus Bismuth, Omeprazole, Amoxicillin, and Clarithromycin Quadruple Therapy: A Randomized, Open-Label, Phase IV TrialHelicobacter 2012; 17(6): 458 doi: 10.1111/j.1523-5378.2012.00971.x
45
Wouter J den Hollander, Ernst J Kuipers. Current pharmacotherapy options for gastritisExpert Opinion on Pharmacotherapy 2012; 13(18): 2625 doi: 10.1517/14656566.2012.747510
46
Francis Mégraud. The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapyTherapeutic Advances in Gastroenterology 2012; 5(2): 103 doi: 10.1177/1756283X11432492
47
Antonio Francesco Ciccaglione, Roberta Tavani, Laurino Grossi, Luigina Cellini, Lamberto Manzoli, Leonardo Marzio. Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment ofHelicobacter pyloriInfection: Two Pilot StudiesHelicobacter 2016; 21(5): 375 doi: 10.1111/hel.12296
48
Wen Zhong Liu, Yong Xie, Hong Lu, Hong Cheng, Zhi Rong Zeng, Li Ya Zhou, Ye Chen, Jiang Bin Wang, Yi Qi Du, Nong Hua Lu. Fifth Chinese National Consensus Report on the management ofHelicobacter pyloriinfectionHelicobacter 2018; 23(2): e12475 doi: 10.1111/hel.12475
49
Yuhong Yuan, Alex C Ford, Khurram J Khan, Javier P Gisbert, David Forman, Grigorios I Leontiadis, Frances Tse, Xavier Calvet, Carlo Fallone, Lori Fischbach, Giuseppina Oderda, Franco Bazzoli, Paul Moayyedi. Optimum duration of regimens forHelicobacter pylorieradicationCochrane Database of Systematic Reviews 2013;  doi: 10.1002/14651858.CD008337.pub2
50
L. Pacifico, J. F. Osborn, C. Anania, D. Vaira, E. Olivero, C. Chiesa. Review article: bismuth-based therapy for Helicobacter pylori eradication in childrenAlimentary Pharmacology & Therapeutics 2012; : n/a doi: 10.1111/j.1365-2036.2012.05055.x
51
Zhiqiang Song, Liya Zhou, Jianzhong Zhang, Lihua He, Peng Bai, Yan Xue. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapyDigestive and Liver Disease 2016; 48(5): 506 doi: 10.1016/j.dld.2016.01.002
52
Guang-Hong Jheng, I-Chen Wu, Hsiang-Yao Shih, Meng-Chieh Wu, Fu-Chen Kuo, Huang-Ming Hu, Chung-Jung Liu, Wen-Hung Hsu, Chi-Tan Hu, Ming-Jong Bair, Chao-Hung Kuo, Deng-Chyang Wu, Ping-I Hsu. Comparison of Second-Line Quadruple Therapies with or without Bismuth forHelicobacter pyloriInfectionBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/163960
53
David Y. Graham, Sun-Young Lee. How to Effectively Use Bismuth Quadruple TherapyGastroenterology Clinics of North America 2015; 44(3): 537 doi: 10.1016/j.gtc.2015.05.003
54
Oguzhan Ozturk, Levent Doganay, Yasar Colak, Feruze Yilmaz Enc, Celal Ulasoglu, Kamil Ozdil, Ilyas Tuncer. Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradicationArab Journal of Gastroenterology 2017; 18(2): 62 doi: 10.1016/j.ajg.2017.05.002